These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11569905)
1. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. Ahrens N; Salama A; Haas J J Neurol; 2001 Aug; 248(8):713-4. PubMed ID: 11569905 [No Abstract] [Full Text] [Related]
2. Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis. Davies SL; Moral MA Drug News Perspect; 2006 Dec; 19(10):632-3. PubMed ID: 17299605 [TBL] [Abstract][Full Text] [Related]
4. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent. Katz KH; Marks JG; Helm KF J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis. Zhu Z; You W; Xie Z; Wang P; Liu Z; Wang C; Bi J J Int Med Res; 2014 Apr; 42(2):530-41. PubMed ID: 24496150 [TBL] [Abstract][Full Text] [Related]
9. From mechanisms to long-term benefits. Mamelok R Transplantation; 2005 Feb; 79(3 Suppl):S43-4. PubMed ID: 15699749 [TBL] [Abstract][Full Text] [Related]
10. Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid. Hiemstra TF; Jones RB; Jayne DR Nephron Clin Pract; 2010; 116(1):c1-10. PubMed ID: 20484933 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Hauser RA; Malek AR; Rosen R Neurology; 1998 Sep; 51(3):912-3. PubMed ID: 9748061 [No Abstract] [Full Text] [Related]
12. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients. Takebe N; Cheng X; Wu S; Bauer K; Goloubeva OG; Fenton RG; Heyman M; Rapoport AP; Badros A; Shaughnessy J; Ross D; Meisenberg B; Tricot G Clin Cancer Res; 2004 Dec; 10(24):8301-8. PubMed ID: 15623606 [TBL] [Abstract][Full Text] [Related]
13. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients. Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953 [TBL] [Abstract][Full Text] [Related]
14. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978 [TBL] [Abstract][Full Text] [Related]